By Joshua Miller
WASHINGTON — Governor Charlie Baker is underscoring the severity and the wide sweep of the opioid addiction crisis in Massachusetts.
In a Monday speech at a prescription drug abuse forum in Washington, he cited statistics about rising yearly number of opioid-related overdose deaths, including from heroin, in the state — up to about 1,000 in 2013 . Read more
Washington, D.C. – In case you missed it, U.S. Senator Rob Portman (R-Ohio) delivered remarks yesterday on the economic impact of the prescription drug abuse epidemic in Ohio and around the country. The event was hosted by the Alliance to Prevent the Abuse of Medicines, in partnership with the U.S. Chamber of Commerce and Roll Call. Portman was joined by Governor Charlie Baker (R-MA), Gov. Terry McAuliffe (D-VA), and Senator Sheldon Whitehouse (D-RI).
By Danielle Hagen
Roll Call | Commentary
Prescription drug abuse is a pervasive public health problem that transcends age and ZIP code. No one sets out to be an addict and every person has a unique story — a grandmother with chronic pain who slowly and unwittingly becomes dependent on her medication, the teenager who steals from a parent’s medicine cabinet and misuses or even sells their medicines, or the war veteran who simply seeks to overcome incomprehensible pain that never stops. Read more
Alliance to Prevent the Abuse of Medicines Issues Open Letter to Office of National Drug Control Policy on Prescription Drug Abuse
WASHINGTON, DC (July 18, 2014) – In an open letter to the Office of National Drug Control Policy (ONDCP), the Alliance to Prevent the Abuse of Medicines (the Alliance) commended the White House for its continued dedication to addressing the issue of prescription drug abuse.
The letter was shared following the release of the 2014 National Drug Control Policy and emphasizes the need for a comprehensive, public health approach to prescription drug abuse that is centered around education, early intervention, drug monitoring, treatment, and safe disposal.
The full text of the letter is included below. Read More
Alliance to Prevent the Abuse of Medicines Supports Comprehensive Approach to Prescription Drug Abuse
WASHINGTON, D.C. (May 19, 2014)— The Alliance to Prevent the Abuse of Medicines (The Alliance)—a non-profit coalition comprised of the American Medical Association (AMA), Cardinal Health,
CVS Caremark, the Healthcare Distribution Management Association (HDMA), Prime Therapeutics, and Teva Pharmaceuticals —today released the following statement in support of a public health-focused, comprehensive approach to dealing with the issue of prescription drug abuse.
The statement comes on the heels of the Clinton Health Matters Initiative and the Bloomberg School of Public Health events on May 13 and 14 at Johns Hopkins University, during which healthcare leaders and lawmakers from across the country discussed about the need for a comprehensive solution to the public health epidemic. Alliance member Prime Therapeutics’ Patrick Gleason presented during a working session about how manufacturers, pharmacies and pharmaceutical benefits managers can be optimally engaged to reduce prescription drug abuse.
by Paige Winfield Cunningham
Or reduce prescription drug abuse, at least. The Alliance to Prevent the Abuse of Medicines — a coalition that includes the AMA and CVS Caremark — is out with nine policy recommendations for lawmakers that could help stem the rising epidemic of drug abuse. Recommendations include prevention, education, early intervention, monitoring, treatment and disposal as core policy principles. Reps. Joe Pitts and Frank Pallone — the chairman and ranking member of E&C’s health subcommittee — attended a briefing yesterday where the group released the ideas.
By Sam Baker, Sophie Novack and Clara Ritger
The Alliance to Prevent the Abuse of Medicines – a partnership of the American Medical Association, Cardinal Health, CVS Caremark, the Healthcare Distribution Management Association, Prime Therapeutics, and Teva Pharmaceuticals — released a set of federal policy recommendations yesterday to address the problem of prescription drug abuse. Announced at a briefing with House Energy & Commerce Health Subcommittee Chair Joe Pitts and Ranking Member Frank Pallone, the recommendations are intended to help lawmakers craft legislation to reduce prescription drug abuse, and focus on prevention and education, early intervention, monitoring, treatment, and disposal. Read all nine solution proposals here
Alliance to Prevent the Abuse of Medicines Releases Federal Policy Recommendations to Combat Prescription Drug Abuse
Coalition of industry leaders outlines key legislative concepts for comprehensive approach to prescription drug abuse epidemic.
WASHINGTON, D.C. (April 9, 2014)—The Alliance to Prevent the Abuse of Medicines (APAM)—a non-profit coalition founded by its members the American Medical Association (AMA), Cardinal Health,
CVS Caremark, the Healthcare Distribution Management Association (HDMA), Prime Therapeutics, and Teva Pharmaceuticals—today released comprehensive, public health-focused policy recommendations to aid lawmakers in the pursuit of significantly reducing prescription drug abuse nationally.
Read more by downloading the